We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dana (DAN) Boosts Portfolio Via Acquisition of Nordresa
Read MoreHide Full Article
In a bid to enhance electrification capabilities, Dana Incorporated (DAN - Free Report) recently acquired Canadian e-powertrain integrator, Nordresa Motors. The financial terms of the transaction have been still kept under wraps. Notably, the transaction is a win-win for both the companies.
This buyout will boost Dana’s business by integrating its portfolio of motors, inverters, chargers, gearboxes and thermal-management products with Nordresa’s battery-management system, electric powertrain controls, and integration expertise. The U.S. auto parts manufacturer will benefit from Nordresa’s expertise in designing and integrating EV systems, which will enable Dana to offer a complete system solution including fully-integrated e-Axles, battery and powertrain controls, and thermal management. On the other hand, the transaction will expand Nordresa’s global footprint and customer base, thereby creating long-term value for customers. Notably, Nordresa's founders will serve in leadership positions at Dana.
Early this year, Dana completed the $600 million acquisition of Oerlikon Group’s Drive Systems segment, which consists of Graziano and Fairfield brands.The deal is likely to enhance Dana’selectronic controls ability for transmissions and drivelines, in turn backing the company’s electrification capabilities in key markets. Notably, Grazino and Fairfield businesses contributed $211 million and $24 million to its sales and profits, respectively, during the second quarter of 2019. Total sales of Dana during the last reported quarter came in at $2.3 billion, marking the 11th consecutive quarter of top-line growth.
Strong backlog and accretive buyouts are expected to drive the company’s financials in 2019.For the current year, it expects $8.95-$9.35 billion in sales and $2.95-$3.45 in adjusted earnings per share.
Zacks Rank & Key Picks
Dana currently carries a Zacks Rank #3 (Hold). Some better-ranked players in the same industry are Wabash National Corporation (WNC - Free Report) , Allison Transmission Holdings, Inc. (ALSN - Free Report) and Gentex Corporation (GNTX - Free Report) . While Wabash flaunts a Zacks Rank #1 (Strong Buy), Allison and Gentex both carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Dana (DAN) Boosts Portfolio Via Acquisition of Nordresa
In a bid to enhance electrification capabilities, Dana Incorporated (DAN - Free Report) recently acquired Canadian e-powertrain integrator, Nordresa Motors. The financial terms of the transaction have been still kept under wraps. Notably, the transaction is a win-win for both the companies.
This buyout will boost Dana’s business by integrating its portfolio of motors, inverters, chargers, gearboxes and thermal-management products with Nordresa’s battery-management system, electric powertrain controls, and integration expertise. The U.S. auto parts manufacturer will benefit from Nordresa’s expertise in designing and integrating EV systems, which will enable Dana to offer a complete system solution including fully-integrated e-Axles, battery and powertrain controls, and thermal management. On the other hand, the transaction will expand Nordresa’s global footprint and customer base, thereby creating long-term value for customers. Notably, Nordresa's founders will serve in leadership positions at Dana.
Early this year, Dana completed the $600 million acquisition of Oerlikon Group’s Drive Systems segment, which consists of Graziano and Fairfield brands.The deal is likely to enhance Dana’selectronic controls ability for transmissions and drivelines, in turn backing the company’s electrification capabilities in key markets. Notably, Grazino and Fairfield businesses contributed $211 million and $24 million to its sales and profits, respectively, during the second quarter of 2019. Total sales of Dana during the last reported quarter came in at $2.3 billion, marking the 11th consecutive quarter of top-line growth.
Strong backlog and accretive buyouts are expected to drive the company’s financials in 2019.For the current year, it expects $8.95-$9.35 billion in sales and $2.95-$3.45 in adjusted earnings per share.
Zacks Rank & Key Picks
Dana currently carries a Zacks Rank #3 (Hold). Some better-ranked players in the same industry are Wabash National Corporation (WNC - Free Report) , Allison Transmission Holdings, Inc. (ALSN - Free Report) and Gentex Corporation (GNTX - Free Report) . While Wabash flaunts a Zacks Rank #1 (Strong Buy), Allison and Gentex both carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>